During the past decade, Simon Lichtiger, M.D. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Simon Lichtiger, M.D." are "Ulcerative Colitis" (2 trials) and "Inflammatory Bowel Disease" (1 trials). Many other conditions were trialed in "Simon Lichtiger, M.D." in a lesser frequency.

Most popular intervention types in "Simon Lichtiger, M.D." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Balsalazide disodium" (1 trials) and "Encapsulated Mesalamine Granules (eMG)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Simon Lichtiger, M.D." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Simon Lichtiger, M.D.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Simon Lichtiger, M.D., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Simon Lichtiger, M.D., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".